Sign in
4

Changes in Ownership

Vera Therapeutics, Inc. Filed Acc 0001415889-24-022620

PRESIDENT AND CEO sold 30,320 shares at an average $36.84 ($1,117,140)

  • PRESIDENT AND CEO acquired 15,625 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Fordyce Marshall PRESIDENT AND CEO 2024-08-28 Option exercise 10b5-1 +14,925 $2.90 $43,235 337,592 D: show line 1 in the form
Fordyce Marshall PRESIDENT AND CEO 2024-08-28 Sale 10b5-1 −14,925 $36.80 $549,241 322,667 D: show line 2 in the form
Fordyce Marshall PRESIDENT AND CEO 2024-08-28 Option exercise 10b5-1 +700 $2.90 $2,028 323,367 D: show line 3 in the form
Fordyce Marshall PRESIDENT AND CEO 2024-08-28 Sale 10b5-1 −700 $37.54 $26,275 322,667 D: show line 4 in the form
Fordyce Marshall PRESIDENT AND CEO 2024-08-28 Sale 10b5-1 −13,995 $36.82 $515,353 308,672 D: show line 5 in the form
Fordyce Marshall PRESIDENT AND CEO 2024-08-28 Sale 10b5-1 −700 $37.53 $26,270 307,972 D: show line 6 in the form
Open-market sales · 30,320 sh · avg $36.84 · $1,117,140

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Fordyce Marshall PRESIDENT AND CEO 2024-08-28 Option exercise · Stock Option (Right to Buy) 10b5-1 −15,625 842,962 D: show line 7 in the form
Loading xslF345X05/form4-08302024_080840.xml…